Part 2 — Cancer Research Globally

If Part I is about what Russia is doing, then this is the broader context.

The more I looked into it, the clearer something became: this is not isolated. This is not one country moving in a different direction. Research across the world is beginning to converge along the same path.

At the center of that convergence is a shared idea: cancer treatment is shifting toward individualized, biology-driven therapies.

The National Cancer Institute describes personalized cancer vaccines as treatments designed using the unique molecular profile of a patient’s tumor—sequencing mutations, identifying neoantigens, and training the immune system to target them.

At Memorial Sloan Kettering Cancer Center, researchers are developing mRNA-based vaccines customized to each patient’s tumor mutations, focusing on precision immune targeting.

The Dana-Farber Cancer Institute has reported that its personalized vaccine platform (NeoVax) can generate strong immune responses using computational modeling to identify effective targets.

The American Association for Cancer Research has highlighted how advances in sequencing and computational biology are making these approaches increasingly feasible, with early clinical signals showing immune activation and delayed recurrence.

Across Europe, Cancer Research UK has expanded access to trials for personalized mRNA cancer vaccines, describing the approach as potentially transformative if results continue to hold.

And in the private sector, BioNTech is advancing individualized mRNA cancer therapies targeting mutations unique to each patient, with a growing global trial pipeline.

What matters here is not who leads or who claims the breakthrough.

What matters is that the direction is the same:

  • Sequence the tumor
  • Identify its unique mutations
  • Use computation to select targets
  • Train the immune system
  • Personalize treatment for the individual

Different countries. Different systems. Increasingly, the same roadmap.

And when science begins to align like this—across institutions, across borders—it usually means something real is taking shape.

But what really matters is what we do with it.

This cannot become another system built to generate billions or trillions for a small group of people to profit on. It has to remain about people.

Humanity is technologically advanced, but behaviorally incomplete. The idea isn’t that we become perfect. It’s that we stop organizing ourselves around systems that require harm to function...

…otherwise, we remain in the same cycle—science and technology advance, while wars and predatory capitalism will continue to undo what we are building; this is the reality of our collective lives and that is rapidly collapsing our planet’s ecosystem. When that happens, there will be no difference between animals of prey and whatever remains of Homo sapiens.

We have the capability. What we don’t have yet is alignment.

That’s where I want to go next—explore what that looks like in practice.


Drifting a bit off topic….but seriously relevant to the conversation: Climate Change

What scientists are actually saying about climate change is more precise than how we usually hear it. They are describing systems that, once pushed past certain thresholds, do not simply return. The language they use matters: irreversible on human timescales, self-sustaining, and self-reinforcing. The Intergovernmental Panel on Climate Change has been clear about this—many changes, especially in the oceans, ice sheets, and sea levels, are irreversible for centuries to millennia. That is not a temporary disruption. That is a shift in how the system functions.

The mechanism behind this is what’s called a tipping point. Not an event—a threshold. Once crossed, the system begins to drive its own change. That is where cascading tipping points come in. One system destabilizes, and it increases the likelihood that others follow, amplifying the effect. This is not fringe thinking. It has been discussed for years in major research and by leading climate scientists. The bottom line is straightforward: once these tipping points begin to cascade, the changes become self-sustaining, self-reinforcing, and effectively irreversible on timescales that matter to human civilization.

Tim Lenton: tipping points can create “self-sustaining or self-propelling change.”
IPCC: many changes are “irreversible for centuries to millennia.”
Hans Joachim Schellnhuber: “If we venture far beyond the 2-degree guardrail… we risk crossing tipping points in the Earth system.”
Stockholm Resilience Centre: crossing critical thresholds may trigger “self-reinforcing feedbacks and tipping dynamics” that amplify warming and destabilize other Earth-system components


Sources — Part II
• National Cancer Institute on personalized cancer vaccines and neoantigen targeting
• Memorial Sloan Kettering Cancer Center on individualized mRNA cancer vaccines
• Dana-Farber Cancer Institute on NeoVax and computational antigen selection
• American Association for Cancer Research on personalized vaccine feasibility and immune response findings
• Cancer Research UK on personalized mRNA cancer vaccine trials
• BioNTech on individualized neoantigen-targeted mRNA oncology platforms

•   National Cancer Institute — https://www.cancer.gov
•   Memorial Sloan Kettering Cancer Center — https://www.mskcc.org
•   Dana-Farber Cancer Institute — https://www.dana-farber.org
•   American Association for Cancer Research — https://www.aacr.org
•   Cancer Research UK — https://www.cancerresearchuk.org
•   BioNTech — https://www.biontech.com